Back to search

Article

DOT1L inhibition exerts anti-tumor effects by activating interferon signaling in breast cancer cells

2025-08-06

Abstract excerpt

<title>Abstract</title> <p>Background DOT1L, a histone H3 lysine 79 (H3K79) methyltransferase, is a potential therapeutic target in various malignancies. In the present study, we aimed to clarify the antitumor effect of DOT1L inhibition in breast cancer. Methods Estrogen receptor (ER)-positive/HER2-negative breast cancer cells (MCF7) and ER-negative/HER2-positive cells (SKBR3) were treated with a DOT1L inhibitor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ad88f01d-fc37-56c0-8237-02ea3f94c179
DOI
10.21203/rs.3.rs-6365502/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
DOT1L inhibition exerts anti-tumor effects by activating interferon signaling in breast cancer cellsDOI 10.21203/rs.3.rs-6365502/v1
Select a neighboring publication to make it the new centre.